Papaverine as an Antiarrhythmic Agent

Sakussow, W.W. , Jr.: Über die Wirkung des Papaverins und des Narkotins auf das Herz. Arch. Exp. Pathol. Pharmakol., 144: 331, 1929.

Melville, K.I. : Cardiac response to posterior pituitary extract as affected by sodium phenobarbital. J. Pharmacol. Exp. Ther. , 66: 107, 1939.

Melville, K.I. : Further studies on the antifibrillatory action of coronary dilator drugs. J. Pharmacol. Exp. Ther., 94: 136, 1948.

Melville, K.I. : The protection action of atabrine against chloroform-adrenaline ventricular fibrillation. J. Pharmacol. Exp. Ther., 87: 350, 1946.

Melville, K.I. : The anti-fibrillation action of papaverine and its value in cardiac resuscitation after chloroform-adrenaline ventricular fibrillation in dogs. Rev. Can. Biol., 7: 236, 1948.

Huggins, R.A. , et al.: The protective action of various agents against chloroform-epinephrine ventricular fibrillation. J. Pharmacol., 95: 312, 1949.

Meirsman-Roobroeck, G.C. : Protective action of parpanit, diparcol and some other drugs against chloroform-adrenaline ventricular fibrillation . Arch. Int. Pharmacodyn. Ther., 83: 353, 1950.

Lindner, E. , Katz, L.N. : Further observations on the action of drugs on the caliber of coronary vessels: papaverine hydrochloride, digitalis derivatives, aminophyllin, caffein, glucose, calcium gluconate and metrazol. J. Pharmacol. Exp. Ther., 72: 306, 1941.

Wégria, R. , Nickerson, N.D. : The effect of papaverine, epinephrine and quinidine on the fibrillation threshold of the mammalian ventricle. J. Pharmacol. Exp. Ther., 75: 50, 1942.

Elek, S.R. , Katz, L.N. : The action of papaverine on the heart of the dog. J. Pharmacol. Exp. Ther., 74: 335, 1942.

Williams, E.M.V. , Szekeres, L. : A comparison of tests for antifibrillatory action. Br. J. Pharmacol., 17: 424, 1961.

Harris, A.A. , et al.: Effects of papaverine upon ectopic ventricular tachycardia produced by myocardial infarction. Circulation, 8: 874, 1953.

Papp, G. , Szekeres, L. , Szmolensky, T. : The effects of quinidine, ajmaline, papaverine and adrenergic beta-receptor inhibitors in experimental BaCl2-arrhythmia developed for the quantitative assay of antiarrhythmic drugs. Acta Physiol. Acad. Sci. Hung. , 32: 365, 1967.

Ben-Ziv, G. , Sulman, F.G. : Effect of tetrahydro-papaverine and homodihydro-papaverine on blood pressure. Arch. Int. Pharmacodyn. Ther., 149: 200, 1964.

Raab, W. , Humphreys, R.J. : Drug action upon myocardial epinephrine-sympathin concentration and heart rate (nitroglycerine, papaverine, priscol, dibenamine hydrochloride). J. Pharmacol. Exp. Ther., 89: 64, 1947.

Chiba, S. , Imai, Y. : Pharmacologic analysis of papaverine-induced positive chronotropic and inotropic effects. Eur. J. Pharmacol., 35: 169, 1976.

Darby, T.D. , Sprouse, J.H. , Walton, R.P. : Evaluation of sympathetic reflex effects on the inotropic action of nitroglycerine, quinidine, papaverine, aminophylline and isoproterenol. J. Pharmacol. Exp. Ther., 122: 386, 1958.

Sodi-Pallares, D. : Personal communication.

Mokotoff, R. , Katz, L.N. : The effect of theophyllin with ethylenediamine (aminophylline) and of papaverine hydrochloride on experimental myocardial infarction in the dog. Am. Heart J., 30: 215, 1945.

Jacques, A. : Clinical uses of papaverine hydrochloride. Curr. Res. Anesthesia Analgesia, 29: 22, 1950.

Kyser, F.A. , Ginsberg, H. , Gilbert, N.C. : The effect of certain drugs upon the cardiotoxic lesions of digitalis in the dog. Am. Heart J., 31: 451, 1946.

Kyser, F.A. , Trump, R. : Further studies on the effect of papaverine upon the cardiotoxic lesions of digitalis in the dog. Am. Heart J., 36: 133, 1948.

Hanna, C. , Schmid, J.R. : Antiarrhythmic actions of coronary vasodilator agents, papaverine, dioxyline and verapamil. Arch. Int. Pharmacodyn. Ther., 185: 228, 1970.

Zipes, D.P. , Besch, H.R. , Watanabe, A.M. : Role of the slow current in cardiac electrophysiology . Circulation, 51: 761, 1975.

Elek, S.R. , Katz, L.N. : Some clinical uses of papaverine in heart disease. J.A.M.A. , 120: 434, 1942.

Reiser, I. , Leslie, R.E. : The action of papaverine in cardiac arrhythmias. Curr. Ther. Res., 6: 690, 1964.

Davies, D.H. : Papaverine in cardiac arrhythmias. Clin. Med., 73: 81, 1966.

Denham, R.M. : Recent advances in cardiac drugs. South. Med. J., 59: 347, 1966.

Greiner, T.H. , Garb, S. : The influence of drugs on the irritability and automaticity of heart muscle. J. Pharmacol. Exp. Ther. , 98: 215, 1950.

DeJongh, D.K. , Van Proosdij-Hartzema , E.G. : Studies on the action of papaverine and perparine on cardiac fibrillation. Acta Physiol. Pharmacol. Neerl. 2: 390, 1951-1952.

Jacques, A. , Sagall, E.L. , Dorfman, A. : Death following the intravenous administration of papaverine hydrochloride: A report of two cases. N. Engl. J. Med., 233: 590, 1945 .

Goodman, L.S. , Gilman, A. : The Pharmacological Basis of Therapeutics. Fourth edition. New York, Macmillan, 1970, p. 754.

White, P.D. : Seven common and important problems in the management of heart diseases and disorders. Med. Clin. North. Am., 28: 1129, 1944 .

Gold, H. : Treatment of coronary artery disease—a conference on therapy. Am. J. Med., 1: 539, 1946.

Katz, L.N. : Re-evaluation of papaverine in the treatment of angina pectoris. J. Lab. Clin. Med., 34: 992, 1949.

Russek, H.I. , Urbach, K.F. , Doerner, A.A. : Choice of a coronary vasodilator in clinical practice, evaluation of effects by electrocardiographic tests. J.A.M.A., 153:207. 1953.

Bassett, A.L. , Hoffman, B.F. : Antiarrhythmic drugs: electrophysiological actions. Am. Rev. Pharmacol., 11: 143, 1971.

Rosen, M.R. , Hoffman, B.F. : Mechanisms of action of antiarrhythmic drugs. Circ. Res., 32: 1, 1973.

Morgan, P.H. , Mathison, I.W. : Arrhythmias and antiarrhythmic drugs: mechanism of action and structure-activity relationships. J. Pharm. Sci. 65: 467, 1976.